Low | Q92793 | CREB-binding protein OS=Homo sapiens OX=9606 GN=CREBBP PE=1 SV=3 | 0.052 | 0.983 | 1 | 1 | 1 | 1 | 2442 | 265.2 | 8.53 | | 1 | | | | 1 | | | 4442772 | 5049729.5 | 3432349.5 | 3558038.75 | 1 | 1 | 1 | 1 | | cell organization and biogenesis;metabolic process;regulation of biological process;response to stimulus | cytoplasm;nucleus | catalytic activity;DNA binding;metal ion binding;protein binding;signal transducer activity | "Pf00439, Pf00569, Pf02135, Pf02172, Pf06001, Pf08214, Pf09030, Pf09770" | 1387 | ENSG00000005339.14 | CREBBP | 16 | "NOTCH1 Intracellular Domain Regulates Transcription; Transcriptional regulation of white adipocyte differentiation; TRAF6 mediated IRF7 activation; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; PPARA activates gene expression; Factors involved in megakaryocyte development and platelet production; RUNX1 regulates transcription of genes involved in differentiation of myeloid cells; YAP1- and WWTR1 (TAZ)-stimulated gene expression; Formation of the beta-catenin:TCF transactivating complex; Pre-NOTCH Transcription and Translation; BMAL1:CLOCK,NPAS2 activates circadian gene expression; RUNX3 regulates YAP1-mediated transcription; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production; Activation of gene expression by SREBF (SREBP); RORA activates gene expression; Regulation of gene expression by Hypoxia-inducible Factor; HATs acetylate histones; Notch-HLH transcription pathway; TRAF3-dependent IRF activation pathway; CD209 (DC-SIGN) signaling; Activation of the TFAP2 (AP-2) family of transcription factors; Attenuation phase; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Transcriptional activation of mitochondrial biogenesis; RUNX3 regulates NOTCH signaling; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release" | Viral carcinogenesis; TGF-beta signaling pathway; Hepatitis B; HIF-1 signaling pathway; FoxO signaling pathway; MicroRNAs in cancer; Epstein-Barr virus infection; Huntington's disease; Pathways in cancer; Prostate cancer; Long-term potentiation; Thyroid hormone signaling pathway; Renal cell carcinoma; Tuberculosis; Glucagon signaling pathway; HTLV-I infection; Melanogenesis; Wnt signaling pathway; Jak-STAT signaling pathway; Adherens junction; Notch signaling pathway; Herpes simplex infection; Cell cycle; cAMP signaling pathway; Influenza A | 0 |